Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma

NCT03467360 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: acetazolamide in combination with platinum and etoposide-based radiochemotherapy
DRUG: acetazolamide in combination with radioimmunotherapy in patients with extensive SCLC

Sponsor

Centre Antoine Lacassagne